Fertilization
Fertilization in Vitro
Spermatozoa
Sperm-Ovum Interactions
Oocytes
Embryo Transfer
Zona Pellucida
Sperm Injections, Intracytoplasmic
Sperm Motility
Pregnancy
Sea Urchins
Pregnancy Rate
Acrosome
Cleavage Stage, Ovum
Acrosome Reaction
Fertilizers
Sperm Capacitation
Cryopreservation
Blastocyst
Ovulation Induction
Infertility, Male
Infertility
Microinjections
Fertility
Parthenogenesis
Sperm Head
Pregnancy Outcome
Semen Preservation
Oocyte Retrieval
Oogenesis
Insemination, Artificial
Follicular Fluid
Reproductive Techniques
Urochordata
Embryo, Mammalian
Fallopian Tubes
Meiosis
Ovarian Follicle
Menotropins
Chorionic Gonadotropin
Semen
Oocyte Donation
Cumulus Cells
Reproductive Techniques, Assisted
Embryo Culture Techniques
Sperm Transport
Echinodermata
Superovulation
In Vitro Oocyte Maturation Techniques
Ovary
Live Birth
Follicle Stimulating Hormone
Epididymis
Oligospermia
Pollen Tube
Micromanipulation
Fallopian Tube Diseases
Embryo, Nonmammalian
Sperm Tail
Contraception, Immunologic
Ovarian Hyperstimulation Syndrome
Blastomeres
Ejaculation
Metaphase
Spermatids
Testis
Cryoprotective Agents
Cytoplasm
Cattle
Seminal Plasma Proteins
Calcium
Sperm Maturation
Seeds
Abortion, Spontaneous
Semen Analysis
Surrogate Mothers
Morula
Gonadotropins
Sperm Retrieval
Suction
Swine
Spermatogenesis
Zebrafish
Buserelin
Culture Media
Nitrogen
Fetal Viability
Vitrification
Cell Nucleus
Ionophores
Gonadotropin-Releasing Hormone
Estradiol
Protamines
Oviducts
Molecular Sequence Data
Calcium Signaling
Progesterone
Gene Expression Regulation, Developmental
Gamete Intrafallopian Transfer
Lytechinus
Gametogenesis
Nafarelin
Hyaluronoglucosaminidase
Mice, Inbred Strains
Preimplantation Diagnosis
Annelida
Gonadotropins, Equine
Chromomycin A3
Endosperm
Phaeophyta
Microscopy, Confocal
Human Characteristics
Culture Techniques
Beginning of Human Life
Follicle Stimulating Hormone, Human
Life
Twins
Zygote Intrafallopian Transfer
Pregnancy, Ectopic
Leuprolide
Follicular Phase
Proto-Oncogene Proteins c-mos
Amino Acid Sequence
Exocytosis
Microscopy, Fluorescence
Insemination, Artificial, Homologous
Models, Biological
Polar Bodies
Species Specificity
Receptors, Cell Surface
Gastropoda
Retrospective Studies
Insemination, Artificial, Heterologous
Mammals
Xenopus laevis
Crosses, Genetic
Nuclear Transfer Techniques
Inositol 1,4,5-Trisphosphate
Phosphoinositide Phospholipase C
Endometriosis
Cells, Cultured
Fluorescent Dyes
Luteinizing Hormone
Triplets
Luteal Phase
Arabidopsis
Aneuploidy
Triptorelin Pamoate
Cell Membrane
Soil
Larva
Single Embryo Transfer
RNA, Messenger
Povidone
Embryo Research
Chromatin
Bivalvia
Calcimycin
Personhood
Thimerosal
Caenorhabditis elegans
Treatment Outcome
Uterus
Ontogeny of expression of a receptor for platelet-activating factor in mouse preimplantation embryos and the effects of fertilization and culture in vitro on its expression. (1/4970)
Platelet-activating factor (PAF; 1-o-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent ether phospholipid. It is one of the preimplantation embryo's autocrine growth/survival factors. It may act via a G protein-linked receptor on the embryo; however, the evidence for this is conflicting. The recent description of the intracellular form of the PAF:acetlyhydrolase enzyme as having structural homology with G proteins and Ras also suggests this as a potential intracellular receptor/transducer for PAF. This study used reverse transcription-polymerase chain reaction to examine the ontogeny of expression of the genes for these proteins in the oocyte and preimplantation-stage embryo. Transcripts for the G protein-linked PAF receptor were detected in the late 2-cell-stage embryo and in all stages from the 4-cell stage to blastocysts. They were also present in unfertilized oocytes and newly fertilized zygotes but only at relatively low levels. The incidence of expression was generally low and variable in late zygotes and early 2-cell embryos. Expression past the 2-cell stage was alpha-amanitin sensitive. The results indicated that mRNA for this receptor is a maternal transcript that was degraded during the zygote-2-cell stage. New expression of the receptor transcript required activation of the zygotic genome. Fertilization of embryos in vitro caused this transcript not to be expressed in the zygote. Culture of zygotes (irrespective of their method of fertilization) caused expression from the zygotic genome to be retarded by more than 24 h. This retardation did not occur if culture commenced at the 2-cell stage. The transcripts for the subunits of intracellular PAF:acetylhydrolase were not detected in oocytes or at any stage of embryo development examined, despite their being readily detected in control tissue. This study confirms the presence of the G protein-linked PAF receptor in the 2-cell embryo and describes for the first time its normal pattern of expression during early development. The adverse effects of in vitro fertilization (IVF) and embryo culture on the expression of this transcript may be a contributing factor for the poor viability of embryos produced in this manner. The reduced expression of PAF-receptor mRNA following IVF predicts that such embryos may have a deficiency in autocrine stimulation and also suggests that supplementation of growth media with exogenous PAF would be only partially beneficial. The effect of IVF and culture may also explain the conflicting literature. (+info)An intact sperm nuclear matrix may be necessary for the mouse paternal genome to participate in embryonic development. (2/4970)
We have been interested in determining the minimally required elements in the sperm head that are necessary in order for the paternal genome to participate in embryogenesis. We used an ionic detergent, mixed alkyltrimethylammonium bromide (ATAB), plus dithiothreitol (DTT) to remove the acrosome and almost all of the perinuclear theca, leaving only the sperm nucleus morphologically intact. We also tested the stability of the sperm nuclear matrix by the ability to form nuclear halos. Sperm nuclei washed in freshly prepared 0.5% ATAB + 2 mM DTT completely decondensed when extracted with salt, but nuclei washed in the same buffer that was 1 wk old, and then extracted with salt, produced nuclear halos, indicating stable nuclear matrices. When we treated sperm heads with freshly prepared ATAB+DTT and injected them into oocytes, none of the oocytes developed into live offspring. In contrast, sperm heads treated in the same way but with 1-wk-old ATAB+DTT solution could support development of about 30% of the oocytes to live offspring. Electron microscopy demonstrated that most of the perinuclear theca had been removed in both cases. These data suggest that at least in the mouse, the only component of the spermatozoa that is crucial for participation in embryologic development is the sperm nucleus with a stable nuclear matrix. (+info)Endometrial oestrogen and progesterone receptors and their relationship to sonographic appearance of the endometrium. (3/4970)
The rapid development of ultrasonographic equipment now permits instantaneous assessment of follicles and endometrium. The sonographic appearance of the endometrium has been discussed in relation to in-vitro fertilization (IVF) cycles. However, a generally agreed view of the relationship of the sonographic appearance to fecundity in IVF cycles has not emerged. We have studied the relationship between steroid receptors and the sonographic appearance of the preovulatory endometrium in natural cycles and ovulation induction cycles. Preovulatory endometrial thickness was not found to be indicative of fecundity, although a preovulatory endometrial thickness of <9 mm related to an elevated miscarriage rate. The preovulatory endometrial echo pattern did not predict fecundity. No relationships were found among endometrial appearance, endometrial steroid receptors and steroid hormone concentrations in serum. Oestrogen or progesterone receptor concentrations were not related to endometrial thickness or to concentrations of serum oestradiol, the only significant correlation being found between the endometrial concentrations of oestrogen and progesterone receptors. The ratio of progesterone:oestrogen receptor concentration was somewhat less in echo pattern B (not triple line) endometrium compared with pattern A (triple line) endometrium. Oestrogen and progesterone receptor concentrations appeared stable on gonadotrophin induction, though fewer numbers were found during clomiphene cycles than in natural cycles. With regard to the distribution of receptor concentration between clomiphene and natural cycles, most women using clomiphene had very low oestrogen receptor populations. Pregnancy rates were low, in spite of high ovulatory rates during clomiphene treatment and were mainly related to low oestrogen receptor concentrations in preovulatory endometrium. (+info)Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes. (4/4970)
CD44 is a polymorphic and polyfunctional transmembrane glycoprotein widely expressed in many types of cells. Here, the expression of this protein on human membrana granulosa was studied by two techniques. Using confocal laser scanning microscopy (CLSM) with the mouse monoclonal antibody to human CD44 (clone G44-26), cells immunoreactive for CD44 were observed in both cumulus and mural granulosa cell masses. On the other hand, using monoclonal antibody to human CD44v9, goat polyclonal antibody to human CD44v3-10 and the clone G44-26, no immunoreactivity for CD44v9 and/or CD44v3-10 was observed in either cell group by flow cytometry. In the flow cytometric analysis of 32 patients, the incidence of CD44 expression in cumulus cells (62.6+/-1.3%) was significantly higher than that in mural granulosa cells (38.5+/-3.2%) (P<0.0001). In the comparison of CD44 expression by flow cytometry according to the maturation of each cumulus-oocyte complex, the incidence of CD44 expression of cumulus cells was significantly higher in the mature group than in the immature group (P<0.05). In a flow cytometric analysis, patients with endometriosis showed a significantly lower incidence of CD44 expression in cumulus cells compared to the infertility of unknown origin group (P<0.05), and compared to both the male infertility group and the unknown origin group in mural granulosa cells (P<0.01). These findings suggest that the standard form of CD44 is expressed in human membrana granulosa with polarity and may play an important role in oocyte maturation. (+info)Origin of DNA damage in ejaculated human spermatozoa. (5/4970)
The molecular basis of many forms of male infertility is poorly defined. One area of research that has been studied intensely is the integrity of the DNA in the nucleus of mature ejaculated spermatozoa. It has been shown that, in men with abnormal sperm parameters, the DNA is more likely to possess strand breaks. However, how and why this DNA damage originates in certain males and how it may influence the genetic project of a mature spermatozoon is unknown. Two theories have been proposed to describe the origin of this DNA damage in mature spermatozoa. The first arises from studies performed in animal models and is linked to the unique manner in which mammalian sperm chromatin is packaged, while the second attributes the nuclear DNA damage in mature spermatozoa to apoptosis. One of the factors implicated in sperm apoptosis is the cell surface protein, Fas. In this review, we discuss the possible origins of DNA damage in ejaculated human spermatozoa, how these spermatozoa arrive in the ejaculate of some men, and what consequences they may have if they succeed in their genetic project. (+info)In-vitro fertilization and culture of mouse embryos in vitro significantly retards the onset of insulin-like growth factor-II expression from the zygotic genome. (6/4970)
In this study, the effect of in-vitro fertilization (IVF) and culture of mouse embryos in vitro on the normal expression of insulin-like growth factor-II (IFG-II) ligand and receptor was examined. The expression of IGF-II increased in a linear fashion at least up to the 8-cell stage of development. IGF-II expression in embryos collected fresh from the reproductive tract was significantly (P < 0.001) greater than in embryos fertilized in the reproductive tract and cultured in vitro (in-situ fertilized: ISF), and its expression was further reduced (P < 0.001) in IVF embryos at all development stages tested. The expression of IGF-II was significantly (P < 0.001) lower when embryos were cultured individually in 100 microl drops compared with culture in groups of 10 in 10 microl drops of medium. The addition of platelet activating factor to culture medium partially overcame this density-dependent decline of expression. Culture of ISF and IVF zygotes also caused the onset of new IGF-II mRNA transcription from the zygotic genome to be significantly (P < 0.001) retarded, until at least the 8-cell stage of development. This effect was greater (P < 0.05) for IVF than for ISF embryos. Neither IVF nor culture had any obvious effect on IFG-II/mannose-6-phosphate receptor (IGF-IIr) mRNA expression. (+info)Detection of benzo[a]pyrene diol epoxide-DNA adducts in embryos from smoking couples: evidence for transmission by spermatozoa. (7/4970)
Tobacco smoking is deleterious to reproduction. Benzo[a]pyrene (B[a]P) is a potent carcinogen in cigarette smoke. Its reactive metabolite induces DNA-adducts, which can cause mutations. We investigated whether B[a]P diol epoxide (BPDE) DNA adducts are detectable in preimplantation embryos in relation to parental smoking. A total of 17 couples were classified by their smoking habits: (i) both partners smoke; (ii) wife non-smoker, husband smokes; and (iii) both partners were non-smokers. Their 27 embryos were exposed to an anti-BPDE monoclonal antibody that recognizes BPDE-DNA adducts. Immunostaining was assessed in each embryo and an intensity score was calculated for embryos in each smoking group. The proportion of blastomeres which stained was higher for embryos of smokers than for non-smokers (0.723 versus 0.310). The mean intensity score was also higher for embryos of smokers (1.40+/-0.28) than for non-smokers (0.38+/-0.14; P = 0.015), but was similar for both types of smoking couples. The mean intensity score was positively correlated with the number of cigarettes smoked by fathers (P = 0.02). Increased mean immunostaining in embryos from smokers, relative to non-smokers, indicates a relationship with parental smoking. The similar levels of immunostaining in embryos from both types of smoking couples suggest that transmission of modified DNA is mainly through spermatozoa. We confirmed paternal transmission of modified DNA by detection of DNA adducts in spermatozoa of a smoker father and his embryo. (+info)Fertilization, embryonic development, and offspring from mouse eggs injected with round spermatids combined with Ca2+ oscillation-inducing sperm factor. (8/4970)
Round spermatids, precursor male gametes, are known to possess the potential to achieve fertilization and embryonic development when injected into eggs. However, injection of spermatids alone seldom activates eggs in the mouse, as spermatids by themselves cannot induce an increase in intracellular Ca2+, a prerequisite for egg activation. We injected a mouse round spermatid into an egg simultaneously with partially purified sperm factor from differentiated hamster spermatozoa. The combined injection produced repetitive Ca2+ increases (Ca2+ oscillations) lasting for at least 4 h as observed at fertilization, and induced activation in 92% of eggs. This method provided 75% fertilization success associated with male and female pronucleus formation and development to 2-cell embryos, while only 7% of eggs were fertilized by injection of a spermatid alone. Of the 2-cell embryos, approximately 50% developed to blastocysts during 5 days of culture in vitro, while no blastocysts were obtained following injection of sperm factor alone. Furthermore, the 2-cell embryos, that were created by spermatids and sperm factor and transplanted into foster mothers, developed into normal offspring, although the percentage was only 22%. All infants grew into healthy adults carrying normal chromosomes. The sperm factor served as a complementary factor for successful fertilization by round spermatid injection. (+info)Causes of Female Infertility
--------------------------
There are several potential causes of female infertility, including:
1. Hormonal imbalances: Disorders such as polycystic ovary syndrome (PCOS), thyroid dysfunction, and premature ovarian failure can affect hormone levels and ovulation.
2. Ovulatory disorders: Problems with ovulation, such as anovulation or oligoovulation, can make it difficult to conceive.
3. Tubal damage: Damage to the fallopian tubes due to pelvic inflammatory disease, ectopic pregnancy, or surgery can prevent the egg from traveling through the tube and being fertilized.
4. Endometriosis: This condition occurs when tissue similar to the lining of the uterus grows outside of the uterus, causing inflammation and scarring that can lead to infertility.
5. Fibroids: Noncancerous growths in the uterus can interfere with implantation of a fertilized egg or disrupt ovulation.
6. Pelvic adhesions: Scar tissue in the pelvis can cause fallopian tubes to become damaged or blocked, making it difficult for an egg to travel through the tube and be fertilized.
7. Uterine or cervical abnormalities: Abnormalities such as a bicornuate uterus or a narrow cervix can make it difficult for a fertilized egg to implant in the uterus.
8. Age: A woman's age can affect her fertility, as the quality and quantity of her eggs decline with age.
9. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and being overweight or underweight can affect fertility.
10. Stress: Chronic stress can disrupt hormone levels and ovulation, making it more difficult to conceive.
It's important to note that many of these factors can be treated with medical assistance, such as medication, surgery, or assisted reproductive technology (ART) like in vitro fertilization (IVF). If you are experiencing difficulty getting pregnant, it is recommended that you speak with a healthcare provider to determine the cause of your infertility and discuss potential treatment options.
Male infertility can be caused by a variety of factors, including:
1. Low sperm count or poor sperm quality: This is one of the most common causes of male infertility. Sperm count is typically considered low if less than 15 million sperm are present in a sample of semen. Additionally, sperm must be of good quality to fertilize an egg successfully.
2. Varicocele: This is a swelling of the veins in the scrotum that can affect sperm production and quality.
3. Erectile dysfunction: Difficulty achieving or maintaining an erection can make it difficult to conceive.
4. Premature ejaculation: This can make it difficult for the sperm to reach the egg during sexual intercourse.
5. Blockages or obstructions: Blockages in the reproductive tract, such as a blockage of the epididymis or vas deferens, can prevent sperm from leaving the body during ejaculation.
6. Retrograde ejaculation: This is a condition in which semen is released into the bladder instead of being expelled through the penis during ejaculation.
7. Hormonal imbalances: Imbalances in hormones such as testosterone and inhibin can affect sperm production and quality.
8. Medical conditions: Certain medical conditions, such as diabetes, hypogonadism, and hyperthyroidism, can affect fertility.
9. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and stress can all impact fertility.
10. Age: Male fertility declines with age, especially after the age of 40.
There are several treatment options for male infertility, including:
1. Medications to improve sperm count and quality
2. Surgery to repair blockages or obstructions in the reproductive tract
3. Artificial insemination (IUI) or in vitro fertilization (IVF) to increase the chances of conception
4. Donor sperm
5. Assisted reproductive technology (ART) such as ICSI (intracytoplasmic sperm injection)
6. Hormone therapy to improve fertility
7. Lifestyle changes such as quitting smoking and alcohol, losing weight, and reducing stress.
It's important to note that male infertility is a common condition and there are many treatment options available. If you're experiencing difficulty conceiving, it's important to speak with a healthcare provider to determine the cause of infertility and discuss potential treatment options.
Infertility can be classified into two main categories:
1. Primary infertility: This type of infertility occurs when a couple has not been able to conceive a child after one year of regular sexual intercourse, and there is no known cause for the infertility.
2. Secondary infertility: This type of infertility occurs when a couple has been able to conceive at least once before but is now experiencing difficulty in conceiving again.
There are several factors that can contribute to infertility, including:
1. Age: Women's fertility declines with age, especially after the age of 35.
2. Hormonal imbalances: Imbalances of hormones such as progesterone, estrogen, and thyroid hormones can affect ovulation and fertility.
3. Polycystic ovary syndrome (PCOS): A common condition that affects ovulation and can cause infertility.
4. Endometriosis: A condition in which the tissue lining the uterus grows outside the uterus, causing inflammation and scarring that can lead to infertility.
5. Male factor infertility: Low sperm count, poor sperm quality, and blockages in the reproductive tract can all contribute to infertility.
6. Lifestyle factors: Smoking, excessive alcohol consumption, being overweight or underweight, and stress can all affect fertility.
7. Medical conditions: Certain medical conditions such as diabetes, hypertension, and thyroid disorders can affect fertility.
8. Uterine or cervical abnormalities: Abnormalities in the shape or structure of the uterus or cervix can make it difficult for a fertilized egg to implant in the uterus.
9. Previous surgeries: Surgeries such as hysterectomy, tubal ligation, and cesarean section can affect fertility.
10. Age: Both male and female age can impact fertility, with a decline in fertility beginning in the mid-30s and a significant decline after age 40.
It's important to note that many of these factors can be treated with medical interventions or lifestyle changes, so it's important to speak with a healthcare provider if you are experiencing difficulty getting pregnant.
There are several possible causes of oligospermia, including:
* Hormonal imbalances
* Varicocele (a swelling of the veins in the scrotum)
* Infections such as epididymitis or prostatitis
* Blockages such as a vasectomy or epididymal obstruction
* Certain medications such as anabolic steroids and chemotherapy drugs
* Genetic disorders
* Environmental factors such as exposure to toxins or radiation
Symptoms of oligospermia may include:
* Difficulty getting an erection
* Premature ejaculation
* Low sex drive
* Painful ejaculation
Diagnosis of oligospermia typically involves a physical exam, medical history, and semen analysis. Treatment will depend on the underlying cause of the condition, but may include medications to improve sperm count and quality, surgery to correct blockages or varicoceles, or assisted reproductive technologies such as in vitro fertilization (IVF).
It's important to note that a low sperm count does not necessarily mean a man is infertile. However, it can make it more difficult to conceive a child. With appropriate treatment and lifestyle changes, some men with oligospermia may be able to improve their fertility and have children.
There are several types of fallopian tube diseases, including:
1. Hydrosalpinx: A condition in which the fallopian tubes become filled with fluid, leading to inflammation and scarring.
2. Salpingitis: An inflammation of the fallopian tubes, often caused by bacterial or fungal infections.
3. Tubal pregnancy: A rare condition in which a fertilized egg implants in the fallopian tube instead of the uterus.
4. Ectopic pregnancy: A condition in which a fertilized egg implants outside of the uterus, often in the fallopian tube.
5. Pelvic inflammatory disease (PID): An infection of the reproductive organs in the pelvis, which can cause scarring and damage to the fallopian tubes.
6. Endometriosis: A condition in which tissue similar to the lining of the uterus grows outside of the uterus, often affecting the fallopian tubes.
7. Adenomyosis: A condition in which tissue similar to the lining of the uterus grows into the muscle of the uterus, often affecting the fallopian tubes.
8. Fimbrial tumors: Rare growths that can occur in the fallopian tubes, often benign but can be cancerous.
9. Mullerian duct anomalies: Congenital abnormalities of the fallopian tubes and other reproductive organs.
10. Oophoritis: Inflammation of the ovaries, which can affect the fallopian tubes.
Fallopian tube diseases can be diagnosed through a variety of tests, including hysterosalpingography (HSG), laparoscopy, and ultrasound. Treatment options vary depending on the specific condition and can include antibiotics for infections, surgery to remove blockages or scar tissue, or assisted reproductive technology such as in vitro fertilization (IVF) if the fallopian tubes are damaged or blocked.
OHSS typically occurs when too many eggs are stimulated to mature during ovulation, leading to an imbalance in hormone levels. The syndrome is more common in women who undergo IVF with high-dose fertility medications, multiple embryo transfer, or those with polycystic ovary syndrome (PCOS).
Symptoms of OHSS may include:
1. Enlarged ovaries that are painful to the touch
2. Abdominal bloating and discomfort
3. Pelvic pain
4. Nausea and vomiting
5. Diarrhea or constipation
6. Abnormal vaginal bleeding
7. Elevated hormone levels (estradiol and/or LH)
OHSS can be diagnosed through ultrasound and blood tests. Treatment options for OHSS include:
1. Cancellation of further fertility treatment until symptoms resolve
2. Medications to reduce hormone levels and inflammation
3. Ultrasound-guided aspiration of fluid from the ovaries
4. Hospitalization for monitoring and supportive care
Prevention is key, and fertility specialists take several measures to minimize the risk of OHSS, such as:
1. Monitoring hormone levels and ultrasound assessment of ovarian response during treatment
2. Adjusting medication dosages based on individual patient needs
3. Limited embryo transfer to reduce the risk of multiple pregnancies
4. Avoiding the use of high-dose stimulation protocols in women with PCOS or other risk factors
Early detection and proper management are crucial to prevent complications and ensure a successful outcome for fertility treatment. If you suspect you may have OHSS, it is essential to consult a fertility specialist immediately.
Here are some key points to consider when discussing azoospermia:
1. Causes: Azoospermia can be caused by various factors, including blockages due to surgery, injury, or infection, hormonal imbalances, anatomical abnormalities like varicocele, and chromosomal abnormalities.
2. Diagnosis: Azoospermia is typically diagnosed through semen analysis, which involves examining a semen sample under a microscope to determine the presence of sperm cells. Other tests may also be performed to identify any underlying causes, such as hormone level testing and ultrasound imaging.
3. Treatment: Treatment for azoospermia depends on the underlying cause, but may include medications to address hormonal imbalances or surgery to correct anatomical abnormalities. Assisted reproductive technologies (ART) like IVF or ICSI can also be used to help achieve pregnancy.
4. Prognosis: The prognosis for azoospermia varies depending on the underlying cause and the effectiveness of treatment. In general, the earlier the condition is diagnosed and treated, the better the prognosis.
5. Impact on fertility: Azoospermia can significantly impact fertility, as the absence of sperm in the semen makes it difficult or impossible to achieve pregnancy through natural means. However, with the help of ART, many men with azoospermia can still achieve fatherhood.
6. Psychological impact: Azoospermia can have significant psychological and emotional impacts on men and their partners, particularly if they are trying to conceive. It is important to provide support and counseling to help cope with the challenges of this condition.
7. Prevention: There is no known prevention for azoospermia, as it is often caused by underlying genetic or hormonal factors. However, identifying and addressing any underlying causes early on can improve outcomes and increase the chances of achieving pregnancy.
* Severe abdominal pain, often on one side of the abdomen
* Vaginal bleeding, which may be heavy or light
* Faintness or dizziness
* Shoulder pain or a sense of heaviness in the shoulder
* Feeling faint or lightheaded
An ectopic pregnancy occurs when a fertilized egg implants outside the uterus, usually in the fallopian tube. This can happen due to various reasons such as pelvic inflammatory disease, previous surgery, or abnormalities in the shape of the uterus or fallopian tubes. If left untreated, an ectopic pregnancy can lead to severe bleeding, organ damage, and even death.
There are several methods for diagnosing an ectopic pregnancy, including:
* Ultrasound: This test uses high-frequency sound waves to create images of the uterus and surrounding tissues. It can help identify the location of the pregnancy and detect any abnormalities.
* Blood tests: These tests can measure the levels of human chorionic gonadotropin (hCG), a hormone produced by the placenta during pregnancy. In an ectopic pregnancy, the level of hCG may be lower than expected.
* Laparoscopy: This is a minimally invasive surgical procedure that involves inserting a thin, lighted tube through a small incision in the abdomen to visualize the pelvic organs. It can help confirm the diagnosis and locate the ectopic pregnancy.
Treatment for an ectopic pregnancy usually involves medication or surgery, depending on the severity of the condition. Medications such as methotrexate can be used to dissolve the pregnancy tissue and allow it to pass out of the body. Surgery may be necessary if the pregnancy is not responding to medication or if there are any complications. In some cases, the fallopian tube may need to be removed if it is severely damaged or if there is a risk of further damage.
Preventive measures for ectopic pregnancy include:
* Using contraception: Using a reliable form of contraception can help prevent unintended pregnancies, which can reduce the risk of an ectopic pregnancy.
* Avoiding risky behaviors: Avoiding risky sexual behaviors such as unprotected sex and multiple partners can help reduce the risk of infection and other complications that can lead to an ectopic pregnancy.
* Getting regular pelvic exams: Regular pelvic exams can help detect any abnormalities or changes in the reproductive organs, which can help identify any potential problems early on.
It is important to note that while these measures can help reduce the risk of an ectopic pregnancy, they are not foolproof and there is always a risk of complications during any pregnancy. If you suspect you may be experiencing an ectopic pregnancy or have any other concerns, it is important to seek medical attention right away.
Endometriosis can cause a range of symptoms, including:
* Painful periods (dysmenorrhea)
* Heavy menstrual bleeding
* Pelvic pain or cramping
* Infertility or difficulty getting pregnant
* Abnormal bleeding or spotting
* Bowel or urinary symptoms such as constipation, diarrhea, or painful urination during menstruation
The exact cause of endometriosis is not known, but it is thought to involve a combination of genetic, hormonal, and environmental factors. Some possible causes include:
* Retrograde menstruation: The backflow of endometrial tissue through the fallopian tubes into the pelvic cavity during menstruation
* Coelomic metaplasia: The transformation of cells that line the abdominal cavity (coelom) into endometrial cells
* Immunological factors: Abnormal immune responses that lead to the growth and accumulation of endometrial cells outside of the uterus
* Hormonal factors: Fluctuations in estrogen levels, which can stimulate the growth of endometrial cells
* Genetic factors: Inherited traits that increase the risk of developing endometriosis
There are several risk factors for developing endometriosis, including:
* Family history: A woman's risk increases if she has a mother, sister, or daughter with endometriosis
* Early onset of menstruation: Women who start menstruating at a younger age may be more likely to develop endometriosis
* Frequent or heavy menstrual bleeding: Women who experience heavy or prolonged menstrual bleeding may be more likely to develop endometriosis
* Polycystic ovary syndrome (PCOS): Women with PCOS are at higher risk for developing endometriosis
* Obesity: Being overweight or obese may increase the risk of developing endometriosis
There is no cure for endometriosis, but there are several treatment options available to manage symptoms and improve quality of life. These may include:
* Hormonal therapies: Medications that reduce estrogen levels or block the effects of estrogen on the endometrium can help manage symptoms such as pain and heavy bleeding
* Surgery: Laparoscopic surgery can be used to remove endometrial tissue and scar tissue, and improve fertility
* Alternative therapies: Acupuncture, herbal remedies, and other alternative therapies may help manage symptoms and improve quality of life
It's important for women with endometriosis to work closely with their healthcare provider to find the best treatment plan for their individual needs. With proper diagnosis and treatment, many women with endometriosis can go on to lead fulfilling lives.
There are several types of aneuploidy, including:
1. Trisomy: This is the presence of an extra copy of a chromosome. For example, Down syndrome is caused by an extra copy of chromosome 21 (trisomy 21).
2. Monosomy: This is the absence of a chromosome.
3. Mosaicism: This is the presence of both normal and abnormal cells in the body.
4. Uniparental disomy: This is the presence of two copies of a chromosome from one parent, rather than one copy each from both parents.
Aneuploidy can occur due to various factors such as errors during cell division, exposure to certain chemicals or radiation, or inheritance of an abnormal number of chromosomes from one's parents. The risk of aneuploidy increases with age, especially for women over the age of 35, as their eggs are more prone to errors during meiosis (the process by which egg cells are produced).
Aneuploidy can be diagnosed through various methods such as karyotyping (examining chromosomes under a microscope), fluorescence in situ hybridization (FISH) or quantitative PCR. Treatment for aneuploidy depends on the underlying cause and the specific health problems it has caused. In some cases, treatment may involve managing symptoms, while in others, it may involve correcting the genetic abnormality itself.
In summary, aneuploidy is a condition where there is an abnormal number of chromosomes present in a cell, which can lead to various developmental and health problems. It can occur due to various factors and can be diagnosed through different methods. Treatment depends on the underlying cause and the specific health problems it has caused.
1. Irregular menstrual cycles, or amenorrhea (the absence of periods).
2. Cysts on the ovaries, which are fluid-filled sacs that can be detected by ultrasound.
3. Elevated levels of androgens (male hormones) in the body, which can cause a range of symptoms including acne, excessive hair growth, and male pattern baldness.
4. Insulin resistance, which is a condition in which the body's cells do not respond properly to insulin, leading to high blood sugar levels.
PCOS is a complex disorder, and there is no single cause. However, genetics, hormonal imbalances, and insulin resistance are thought to play a role in its development. It is estimated that 5-10% of women of childbearing age have PCOS, making it one of the most common endocrine disorders affecting women.
There are several symptoms of PCOS, including:
1. Irregular menstrual cycles or amenorrhea
2. Weight gain or obesity
3. Acne
4. Excessive hair growth on the face, chest, and back
5. Male pattern baldness
6. Infertility or difficulty getting pregnant
7. Mood changes, such as depression and anxiety
8. Sleep apnea
PCOS can be diagnosed through a combination of physical examination, medical history, and laboratory tests, including:
1. Pelvic exam: A doctor will examine the ovaries and uterus to look for cysts or other abnormalities.
2. Ultrasound: An ultrasound can be used to detect cysts on the ovaries and to evaluate the thickness of the uterine lining.
3. Hormone testing: Blood tests can be used to measure levels of androgens, estrogen, and progesterone.
4. Glucose tolerance test: This test is used to check for insulin resistance, which is a common finding in women with PCOS.
5. Laparoscopy: A small camera inserted through a small incision in the abdomen can be used to visualize the ovaries and uterus and to diagnose PCOS.
There is no cure for PCOS, but it can be managed with lifestyle changes and medication. Treatment options include:
1. Weight loss: Losing weight can improve insulin sensitivity and reduce androgen levels.
2. Hormonal birth control: Birth control pills or other hormonal contraceptives can help regulate menstrual cycles and reduce androgen levels.
3. Fertility medications: Clomiphene citrate and letrozole are commonly used to stimulate ovulation in women with PCOS.
4. Injectable fertility medications: Gonadotropins, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH), can be used to stimulate ovulation.
5. Surgery: Laparoscopic ovarian drilling or laser surgery can improve ovulation and fertility in women with PCOS.
6. Assisted reproductive technology (ART): In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) can be used to help women with PCOS conceive.
7. Alternative therapies: Some complementary and alternative therapies, such as acupuncture and herbal supplements, may be helpful in managing symptoms of PCOS.
It is important for women with PCOS to work closely with their healthcare provider to develop a treatment plan that meets their individual needs and goals. With appropriate treatment, many women with PCOS can improve their menstrual regularity, fertility, and overall health.
1. Ovarian cysts: These are fluid-filled sacs that form on the ovaries. They can be benign (non-cancerous) or malignant (cancerous). Common symptoms include pelvic pain, bloating, and irregular periods.
2. Polycystic ovary syndrome (PCOS): This is a hormonal disorder that affects ovulation and can cause cysts on the ovaries. Symptoms include irregular periods, acne, and excess hair growth.
3. Endometriosis: This is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often on the ovaries. Symptoms include pelvic pain, heavy bleeding, and infertility.
4. Ovarian cancer: This is a type of cancer that affects the ovaries. It is rare, but can be aggressive and difficult to treat. Symptoms include abdominal pain, bloating, and vaginal bleeding.
5. Premature ovarian failure (POF): This is a condition in which the ovaries stop functioning before the age of 40. Symptoms include hot flashes, vaginal dryness, and infertility.
6. Ovarian torsion: This is a condition in which the ovary becomes twisted, cutting off blood flow. Symptoms include severe pelvic pain, nausea, and vomiting.
7. Ovarian abscess: This is an infection that forms on the ovaries. Symptoms include fever, abdominal pain, and vaginal discharge.
8. Ectopic pregnancy: This is a condition in which a fertilized egg implants outside the uterus, often on the ovaries. Symptoms include severe pelvic pain, bleeding, and fainting.
9. Ovarian cysts: These are fluid-filled sacs that form on the ovaries. They can be benign or cancerous. Symptoms include abdominal pain, bloating, and irregular periods.
10. Polycystic ovary syndrome (PCOS): This is a hormonal disorder that affects the ovaries, causing symptoms such as irregular periods, cysts on the ovaries, and excess hair growth.
It's important to note that these are just a few examples of the many possible conditions that can affect the ovaries. If you experience any persistent or severe symptoms in your pelvic area, it is important to seek medical attention to determine the cause and receive proper treatment.
Natural cycle in vitro fertilization
In vitro fertilisation
History of in vitro fertilisation
Elective genetic and genomic testing
Pharmacokinetics of progesterone
Assisted reproductive technology
Newton's Apple
Artificial insemination
Genetics and abortion
Double fertilization
University of Mississippi Medical Center
Transvaginal oocyte retrieval
Integris Health
Elizabeth Jordan Carr
Ernestine Gwet Bell
In vitro maturation
1959 in science
Twin study
Cyclofenil
Embryonic stem cell
Pogus Caesar
Arginine kinase
Norbert Gleicher
Gastrulation
Estradiol (medication)
Dmitri Dozortsev
Billie Eilish
Gonadotropin-releasing hormone agonist
Biomedicine
Endometriosis and infertility
New Reform Party of Ontario
Genomic imprinting
Fragmentation (cell biology)
Mitochondrial DNA
List of Puerto Rican scientists and inventors
List of Indians in Singapore
NAD+ kinase
Biometal (biology)
Positive pressure
Brian Dale
Megaspore
Schistocephalus solidus
Corn silk
Thalassoma bifasciatum
Age and female fertility
Stem cell laws
Helen Szoke
Adam Nash (savior sibling)
Good Newwz
Chrissy Conant
Oocyte selection
List of Royal Pains characters
Howard W. Jones
Timeline of LGBT history in the United Kingdom
4-hydroxyphenylacetaldehyde oxime monooxygenase
Diana W. Bianchi
Obesity and fertility
Catholic Church
In vitro fertilization (IVF): MedlinePlus Medical Encyclopedia
In vitro fertilization (IVF): MedlinePlus Medical Encyclopedia
NIH Guide: RESEARCH INVOLVING HUMAN IN VITRO FERTILIZATION
JCI -
Mice generated by in vitro fertilization exhibit vascular dysfunction and shortened life span
NNN / First Puppies Born by In Vitro Fertilization
Study Considers Link Between Skull Deformity, In Vitro Fertilization - Consumer Health News | HealthDay
In vitro fertilisation - wikidoc
Frontiers | An Overview of Systematic Reviews of Acupuncture for Infertile Women Undergoing in vitro Fertilization and Embryo...
Q&A 0719 - In Vitro Fertilization | Douglas Jacoby
Acupuncture versus placebo acupuncture for in vitro fertilisation: a systematic review and meta-analysis - PubMed
Is in vitro fertilization safe for plus sized women? - In Vitro Fertilization (IVF) Questions & Answers | FertilityProRegistry...
Urinary Phthalate Metabolite Concentrations and Reproductive Outcomes among Women Undergoing in Vitro Fertilization: Results...
WHO EMRO | Evaluation of effect of silymarin on granulosa cell apoptosis and follicular development in patients undergoing in...
Swedish in-Vitro Fertilisation Study
Best In-Vitro Fertilization Treatment Clinic | Reproductive Medicine Center India
in vitro fertilization
Vitro Fertilization - Hektoen International
In Vitro Fertilization (IVF) - MEIH
In vitro fertilisation
In Vitro Fertilization Archives - IVF Advanced
What Is In-Vitro-Fertilization (IVF)?
in vitro fertilization
In-Vitro Fertilization, 4th Edition ABC Books
In Vitro Fertilization (IVF) & Embryology Lab - TRIO
In vitro fertilization (IVF) Metropolitan Urology Group
Resources for Pacific In Vitro Fertilization Institute
In Vitro Fertilisation - Valentine202.net
Our In Vitro Fertilization Price in Spain - Reproclinic
What is Natural Cycle In Vitro Fertilization? - LesMaternity
Intracytoplasmic Sperm Inj1
- Health and Well-Being Outcomes of Adolescents Conceived Through In Vitro Fertilization and Intracytoplasmic Sperm Injection. (bvsalud.org)
Embryo7
- Currently, more and more subfertility couples are opting for combined acupuncture to improve the success rate of in vitro fertilization and embryo transfer (IVF-ET). (frontiersin.org)
- In vitro fertilization and embryo transfer (IVF-ET) is an effective treatment method for subfertility couples ( 6 , 7 ). (frontiersin.org)
- The fertilization of an egg by a sperm gives rise to a zygote or pre-embryo which is kept in the incubator for about two to five days where it continues to grow and divide. (ivf-clinic-india.com)
- If the fertilisation is successful, the fertilised egg will be transferred into the uterus, within which it will develop into an embryo . (en-academic.com)
- In the case of in vitro fertilisation using donor eggs, this step is carried out on the egg donor and the woman who will receive the embryos has her endometrium hormonally prepared so that it is at the optimum stage to receive the embryo. (reproclinic.com)
- Evidence suggests that paternal exposure to environmental chemicals may adversely affect reproductive outcomes.We evaluated associations of paternal phenol urinary concentrations with fertilization rate, embryo quality, implantation, and live birth.Male-female couples who underwent in vitro fertilization (IVF) and/or intrauterine insemination (IUI) cycles in a prospective study of environmental determinants of fertility and pregnancy outcomes were included. (nih.gov)
- Associations between male urinary phenol concentrations and fertilization rate, embryo quality, implantation, and live birth were investigated using generalized linear mixed models to account for multiple cycles per couple.Couples (n = 218) underwent 195 IUI and 211 IVF cycles. (nih.gov)
Eggs10
- If my tubes are tied, can we use my eggs and my husband's sperm during the in vitro fertilization process? (fertilityproregistry.com)
- In-vitro fertilization (IVF) is the process of fertilizing eggs with the sperm outside of the human body. (ivf-clinic-india.com)
- A couple of hours after egg collection, the male partner is asked toprovide semen sample following which the eggs are mixed with the sperm in a petri-dish to allow fertilization. (ivf-clinic-india.com)
- In the laboratory, the identified eggs are stripped of surrounding cells and prepared for fertilisation. (en-academic.com)
- According to a June 22, 2016 editorial in The Seattle Times , opposition is being spearheaded by the conservative Family Research Council on the grounds that in vitro fertilization could result in the destruction of fertilized eggs (which is tantamount, in the eyes of Catholic and Protestant religious fundamentalists, to abortion). (wordpress.com)
- Medications are prescribed to promote production of more eggs for In-Vitro Fertilization procedure. (angelhealths.com)
- Sperms and eggs are exposed to each other for fertilization. (angelhealths.com)
- In vitro fertilization (IVF) is a procedure that involves collecting eggs from the ovaries and fertilizing them with sperm in a laboratory. (gourology.com)
- The third step of this treatment is the insemination of the eggs in the laboratory, which can be done conventionally (conventional fertilisation which consists of putting the best sperm in contact with the eggs for a few hours so that they can fertilise the egg) or using the ICSI technique (injecting the sperm directly into the egg). (reproclinic.com)
- This paper presents a discussion of Freudian psychoanalytic theory, especially the concepts of infantile sexuality and narcissism, and the results of scientific partial research on emotional experiences of couples who underwent in vitro fertilization using donor eggs, aiming to understand the emotional aspects of these couples within the framework of psychoanalysis. (bvsalud.org)
Sperm5
- In vitro fertilization (IVF) is the joining of a woman's egg and a man's sperm in a laboratory dish. (medlineplus.gov)
- Fertilization means the sperm has attached to and entered the egg. (medlineplus.gov)
- If the doctor thinks the chance of fertilization is low, the sperm may be directly injected into the egg. (medlineplus.gov)
- In infertile couples where women have blocked or absent fallopian tubes or where men have low sperm counts, the technique of in-vitro fertilization (IVF) offers a chance at parenthood to couples who until recently would have had no hope of having a "biologically related" child. (ivf-clinic-india.com)
- The process in which the sperm fertilises the egg takes place outside the woman's reproductive system, in the laboratory, hence the term in vitro, which means outside the body. (reproclinic.com)
Intrauterine insemination1
- Subsequently, intrauterine insemination, ovarian stimulation, and in vitro fertilization have been successfully used in these patients. (medscape.com)
Infertility3
- ABSTRACT To investigate the effects of silymarin on follicular development, we enrolled 40 healthy women undergoing in vitro fertilization (IVF) due to male factor infertility in this trial. (who.int)
- Infertility Treatment: How late is it to go for In Vitro. (valentine202.net)
- Men's Intake of Vitamin C and β-Carotene Is Positively Related to Fertilization Rate but Not to Live Birth Rate in Couples Undergoing Infertility Treatment. (nih.gov)
Outcomes2
Woman's1
- Embryos are placed into the woman's womb 3 to 5 days after egg retrieval and fertilization. (medlineplus.gov)
Petri-dish2
- The term "in vitro", from the Latin root meaning "in glass", is used, because early biological experiments involving cultivation of tissues outside the living organism from which they came, were carried out in glass containers such as " beaker s, test tube s, or petri dish es. (en-academic.com)
- However "in vitro" fertilisation is usually performed in the shallower containers called petri dish es. (en-academic.com)
Ovarian1
- For some women, who don't react well or simply don't want ovarian stimulation, natural cycle in vitro fertilization may be a good option to become pregnant. (lesmaternity.com)
Couples2
- RESEARCH OBJECTIVES Many infertile couples have been treated with a variety of assisted reproductive techniques, ranging from such simple methods as timed natural intercourse or artificial insemination, through ovulation induction, to in vitro technologies such as IVF. (nih.gov)
- Many women or couples, nowadays, wonder which is the i n vitro fertilization Price in Spain ? (reproclinic.com)
Pregnancy1
- 3 The pregnancy rate is about the same for IVF using natural fertilization or ICSI. (nih.gov)
India1
- Patients can choose to visit the top IVF center in India for Tube Reversal or In-Vitro Fertilization. (ivfadvanced.com)
Pregnant3
- Can a 46 year old women get pregnant via in vitro fertilization? (fertilityproregistry.com)
- In vitro fertilization, or IVF, is an effective and common type of assisted reproductive technique to help women to become pregnant. (angelhealths.com)
- Review Boards in connection with activi- shall be contingent upon the avail- ties involving fetuses, pregnant women, ability of appropriated funds of the em- or human in vitro fertilization. (nih.gov)
Acupuncture1
- To evaluate the efficacy of acupuncture compared to placebo acupuncture for women undergoing in vitro fertilisation (IVF) in a systematic review and meta-analysis. (nih.gov)
Semen1
- In the meantime, semen is prepared for fertilisation by removing inactive cells and seminal fluid. (en-academic.com)
Women5
- Is in vitro fertilization safe for plus sized women? (fertilityproregistry.com)
- Can a women get in vitro fertilization if she no longer has a period? (fertilityproregistry.com)
- And Planned Parenthood clinics are under constant threat of losing state and federal funding despite the fact that most offer a full range of women's health services (including cancer screening, in vitro fertilization, and sex education) that would not otherwise be accessible to women of scarce resources. (wordpress.com)
- Some insurance plans cover in vitro fertilization (IVF) but not the injections that women may also require. (angelhealths.com)
- Dr. Rinehart shares important tips for women undergoing in vitro fertilization. (aurorahealthcareblog.org)
Concentrations1
- Paternal phenol concentrations were not associated with fertilization or live birth following IVF. (nih.gov)
Process2
- How long does the In Vitro Fertilization process take? (fertilityproregistry.com)
- The in vitro fertilization process can last anywhere from four to six weeks prior to egg retrieval. (angelhealths.com)
Cycle4
- Ces patientes ont été soumises à une induction d'ovulation et ont reçu, sur la base d'une répartition aléatoire et en aveugle, de la silymarine (70 mg × 3 fois par jour) ou un placebo, dès le début du cycle d'induction. (who.int)
- What is Natural Cycle In Vitro Fertilization? (lesmaternity.com)
- That is why we say that fertilization is done in the Natural Ovulation Cycle . (lesmaternity.com)
- The aim of natural cycle in vitro stimulation is to obtain a few high-quality oocytes. (lesmaternity.com)
Implantation1
- The Short-read Transpore Rapid Karyotyping (STORK) test can detect extra or missing chromosomes (i.e., aneuploidy) using samples collected from prenatal tests, such as amniocentesis and chorionic villus sampling, as well as tissue obtained from miscarriage and biopsies from pre-implantation embryos produced using in vitro fertilization (IVF). (nih.gov)
Human4
- This Program Announcement, Research Involving Human In Vitro Fertilization, is related to the priority area of family planning. (nih.gov)
- Human in vitro fertilization : a case study in the regulation of medical innovation / Jennifer Gunning and Veronica English. (who.int)
- Even if it is defenseless and dependent, a new human life is created at fertilization. (newevangelizers.com)
- Applications and proposals lacking quest either (1) indemnification to sat- definite plans for involvement of human isfy a verdict, judgment or award en- subjects. (nih.gov)
Rate2
- This made it possible to " achieve a success rate of 80-90% fertilization" said Travis. (nextnature.net)
- Generalized linear mixed models with random intercepts were fitted to account for multiple ART cycles per woman while adjusting for confounding.Men's vitamin C intake was positively associated with fertilization rate. (nih.gov)
Technique2
- By 2016 around 6.5 million babies are born by using in-vitro fertilization technique. (angelhealths.com)
- In this assisted fertilization technique the extraction of quality oocytes is achieved without the need for hormonal stimulation. (lesmaternity.com)
Procedure1
- Today, the term "in vitro" is used to refer to any biological procedure that is performed outside the organism it would normally be occurring in, to distinguish it from an in vivo procedure, where the tissue remains inside the living organism within which it is normally found. (en-academic.com)
News1
- FRIDAY, Oct. 29, 2021 (HealthDay News) -- Among infants and children with the skull deformity known as craniosynostosis, 4 percent were conceived by in vitro fertilization (IVF), according to a study published online Sept. 20 in The Journal of Craniofacial Surgery . (healthday.com)
Term1
- Cryopreservation of germplasm for long term storage, in vitro fertilization and rederivation of lines. (nih.gov)
Body1
- In vitro means outside the body. (medlineplus.gov)
Successful1
- You can also take advantage of it if you have already undergone other assisted fertilization processes without successful multi-follicular growth. (lesmaternity.com)
Long1
- In-Vitro Fertilization has been used for a long time and has a safe track record. (angelhealths.com)
Models1
- Relating in vitro to in vivo exposures with physiologically-based tissue dosimetry and tissue response models. (cdc.gov)